Trial Profile
Antiarrhythmic and antiremodelation effects of ivabradin in ICD carriers.
Status:
Recruiting
Phase of Trial:
Phase IV
Latest Information Update: 15 Dec 2016
Price :
$35
*
At a glance
- Drugs Ivabradine (Primary)
- Indications Heart failure
- Focus Therapeutic Use
- 15 Dec 2016 New trial record